|
2023
|
Invention
|
Treatment of familial adenomatous polyopsis using a 13-membered macrolide. 9a1-61-61-61-61-61-610... |
|
|
Invention
|
Synthetic processes and intermediates for preparing therapeutic azaketolides. The present inventi... |
|
|
Invention
|
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation. P... |
|
|
Invention
|
Macrolides for treating genetic diseases. Provided are 13 -membered ribosome targeting compounds ... |
|
|
Invention
|
Macrolides with modified desosamine sugars and uses thereof.
Provided are macrolide compounds fo... |
|
2022
|
Invention
|
Compounds for treating genetic diseases.
Provided are 13-membered ribosome targeting compounds t... |
|
|
Invention
|
Compounds for treating genetic diseases. Provided are 13-membered ribosome targeting compounds th... |
|
2019
|
Invention
|
C10-alkylene substituted 13-membered macrolides and uses thereof.
Provided are 13-membered macro... |
|
|
Invention
|
C10-cyclic substituted 13-membered macrolides and uses thereof.
Provided are 13-membered macroli... |
|
|
Invention
|
C10-alkylene substituted 13-membered macrolides and uses thereof. Provided are 13-membered macrol... |
|
|
Invention
|
C11-cyclic substituted 13-membered macrolides and uses thereof. Provided are 13-membered macrolid... |
|
2018
|
Invention
|
Macrolides with modified desosamine sugars and uses thereof. Provided are macrolide compounds for... |
